ZACHARY DALLAS: Open Payments
NPI 1407303720 · KILLEEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 26 payments from 11 companies in 2025. Trend: 2023 $446 · 2024 $699 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $226 |
| Amgen Inc. | 3 | $67 |
| PFIZER INC. | 2 | $54 |
| Medtronic, Inc. | 2 | $50 |
| Boston Scientific Corporation | 2 | $38 |
| Stryker Corporation | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: LEQVIO, ELIQUIS, REPATHA, FLOWTRIEVER, EMPRINT, General - Embolics, LifeVest, SYMPLICITY G3.
Industry payments across TX — which companies pay providers there.
